1. Home
  2. NURO vs SILO Comparison

NURO vs SILO Comparison

Compare NURO & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NURO
  • SILO
  • Stock Information
  • Founded
  • NURO 1996
  • SILO 2010
  • Country
  • NURO United States
  • SILO United States
  • Employees
  • NURO N/A
  • SILO N/A
  • Industry
  • NURO Medical/Dental Instruments
  • SILO Apparel
  • Sector
  • NURO Health Care
  • SILO Consumer Discretionary
  • Exchange
  • NURO Nasdaq
  • SILO Nasdaq
  • Market Cap
  • NURO 8.2M
  • SILO 8.8M
  • IPO Year
  • NURO N/A
  • SILO N/A
  • Fundamental
  • Price
  • NURO $4.37
  • SILO $1.47
  • Analyst Decision
  • NURO
  • SILO
  • Analyst Count
  • NURO 0
  • SILO 0
  • Target Price
  • NURO N/A
  • SILO N/A
  • AVG Volume (30 Days)
  • NURO 22.3K
  • SILO 600.9K
  • Earning Date
  • NURO 02-20-2025
  • SILO 02-18-2025
  • Dividend Yield
  • NURO N/A
  • SILO N/A
  • EPS Growth
  • NURO N/A
  • SILO N/A
  • EPS
  • NURO N/A
  • SILO N/A
  • Revenue
  • NURO $3,767,764.00
  • SILO $72,102.00
  • Revenue This Year
  • NURO N/A
  • SILO $1.86
  • Revenue Next Year
  • NURO N/A
  • SILO N/A
  • P/E Ratio
  • NURO N/A
  • SILO N/A
  • Revenue Growth
  • NURO N/A
  • SILO N/A
  • 52 Week Low
  • NURO $2.66
  • SILO $0.77
  • 52 Week High
  • NURO $4.73
  • SILO $4.50
  • Technical
  • Relative Strength Index (RSI)
  • NURO 66.28
  • SILO 43.57
  • Support Level
  • NURO $4.16
  • SILO $1.42
  • Resistance Level
  • NURO $4.39
  • SILO $1.82
  • Average True Range (ATR)
  • NURO 0.08
  • SILO 0.17
  • MACD
  • NURO 0.01
  • SILO -0.07
  • Stochastic Oscillator
  • NURO 91.67
  • SILO 5.97

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: